SMTL ID : 3g0u.1

Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 4

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x ORO: OROTIC ACID(Non-covalent)

ORO.1: 12 residues within 4Å: Chain A: K.71, N.116, R.117, Y.118, G.119, F.120, N.183, S.186, N.188, N.255, T.256 Ligands: FMN.2 10 PLIP interactions: 10 interactions with chain A Hydrogen bonds: A:N.116, A:G.119, A:F.120, A:N.183, A:N.188, A:N.255, A:N.255 Water bridges: A:S.186, A:S.186 Salt bridges: A:K.71

1 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)

FMN.2: 25 residues within 4Å: Chain A: A.66, A.67, G.68, K.71, G.90, S.91, N.116, Y.118, N.152, N.183, K.226, T.254, N.255, T.256, S.276, G.277, L.280, V.304, G.305, G.306, L.326, Y.327, T.328 Ligands: ORO.1, MDY.3 22 PLIP interactions: 22 interactions with chain A Hydrophobic interactions: A:N.116, A:Y.118, A:Y.327 Hydrogen bonds: A:A.67, A:K.71, A:S.91, A:S.91, A:N.152, A:K.226, A:K.226, A:N.255, A:S.276, A:G.277, A:G.306, A:Y.327, A:T.328, A:T.328 Water bridges: A:A.67, A:G.305, A:V.307, A:V.307, A:V.307

1 x MDY: (2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide(Non-covalent)

MDY.3: 17 residues within 4Å: Chain A: Y.9, L.13, M.14, L.17, P.23, A.26, H.27, A.30, T.34, F.69, V.105, R.107, Y.327, L.330, T.331, P.335 Ligands: FMN.2 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:Y.9, A:L.13, A:L.17, A:H.27, A:A.30, A:V.105, A:T.331, A:P.335 Hydrogen bonds: A:R.107 Water bridges: A:Q.18

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Davies, M. et al., Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases. J.Med.Chem. (2009)

Release Date

2009-06-09

Peptides

Dihydroorotate dehydrogenase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dihydroorotate dehydrogenase

Related Entries With Identical Sequence